Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

Author:

Armstrong Jane F.1ORCID,Campo Brice2,Alexander Stephen P. H.3ORCID,Arendse Lauren B.4,Cheng Xiu5,Davenport Anthony P.6,Faccenda Elena1,Fidock David A.78,Godinez‐Macias Karla P.9,Harding Simon D.1ORCID,Kato Nobutaka5,Lee Marcus C. S.10,Luth Madeline R.11,Mazitschek Ralph12,Mittal Nimisha13,Niles Jacquin C.14,Okombo John7,Ottilie Sabine11,Pasaje Charisse Flerida A.14ORCID,Probst Alexandra S.15,Rawat Mukul10,Rocamora Frances11,Sakata‐Kato Tomoyo5,Southan Christopher1,Spedding Michael16ORCID,Tye Mark A.12,Yang Tuo17,Zhao Na5,Davies Jamie A.1

Affiliation:

1. Deanery of Biomedical Sciences The University of Edinburgh Edinburgh UK

2. Medicines for Malaria Venture Geneva Switzerland

3. School of Life Sciences University of Nottingham Medical School Nottingham UK

4. Drug Discovery and Development Centre (H3D), South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry, and Institute of Infectious Disease and Molecular Medicine University of Cape Town Cape Town South Africa

5. Global Health Drug Discovery Institute Beijing China

6. Experimental Medicine and Immunotherapeutics University of Cambridge Cambridge UK

7. Department of Microbiology and Immunology Columbia University Irving Medical Center New York New York USA

8. Center for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medicine Columbia University Irving Medical Center New York New York USA

9. Bioinformatics and Systems Biology Graduate Program University of California, San Diego (UCSD) La Jolla California USA

10. Parasites and Microbes Programme Wellcome Sanger Institute Hinxton UK

11. Department of Pediatrics University of California San Diego School of Medicine La Jolla California USA

12. Center for Systems Biology Massachusetts General Hospital Boston Massachusetts USA

13. Thermo Fisher Scientific San Diego California USA

14. Department of Biological Engineering Massachusetts Institute of Technology Cambridge Massachusetts USA

15. Department of Immunology and Infectious Diseases Harvard TH Chan School of Public Health Boston Massachusetts USA

16. Spedding Research Solutions SAS Le Vésinet France

17. Department of Pediatrics, School of Medicine University of California, San Diego La Jolla California USA

Abstract

Antimalarial drug discovery has until recently been driven by high‐throughput phenotypic cellular screening, allowing millions of compounds to be assayed and delivering clinical drug candidates. In this review, we will focus on target‐based approaches, describing recent advances in our understanding of druggable targets in the malaria parasite. Targeting multiple stages of the Plasmodium lifecycle, rather than just the clinically symptomatic asexual blood stage, has become a requirement for new antimalarial medicines, and we link pharmacological data clearly to the parasite stages to which it applies. Finally, we highlight the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY, a web resource developed for the malaria research community that provides open and optimized access to published data on malaria pharmacology.

Funder

British Pharmacological Society

Medicines for Malaria Venture

Publisher

Wiley

Subject

Pharmacology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3